UPC Analytics
ENDE
Overview · Filed: Oct 31, 2024

UPC_CFI_642/2024

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

RevocationMain Revocation ActionMilan CDRevocationCase Closed
Parties

Claimants

  • AMGEN Switzerland AG Vilniaus filialas

Respondents

Judges
  • Andrea Postiglione
  • Marije Knijff
  • Rudi Goedeweeck
Patents
  • EP3167888
CPC codes: A61P31/04, A61P25/18, A61P29/02, A61K39/395, A61K2039/505, A61P7/02, A61P25/26, A61P13/02, A61P15/10, A61P17/00, A61P7/00, A61P25/28

Technology area: Biotech · Antibody

Sector: Organic Chemistry

Outcome
Filed: Oct 31, 2024
First decided:
Language: English
Open on UPC Registry